VEGF Mediates Tumor Growth and Metastasis by Affecting the Expression of E-Cadherin and N-Cadherin Promoting Epithelial to Mesenchymal Transition in Gastric Cancer
Authors:
Open Access
- 6 July 2023
- journal article
- research article
- Published by SAGE Publications in Clinical Medicine Insights: Oncology
- Vol. 17
Abstract
Background: Gastric cancer (GC) is the fifth leading cancer in the world, and there is a high mortality rate in China. Exploring the relationship between the prognosis of GC and the expression of related genes is helpful to further understand the common characteristics of the occurrence and development of GC and provide a new method for the identification of early GC, so as to provide the best therapeutic targets. Methods: Vascular endothelial growth factor (VEGF) and markers of epithelial-mesenchymal transition (EMT) were investigated immunohistochemically using tumor samples obtained from 196 GC tissues and adjacent tumor tissues. The correlation of the expression level with histopathologic features and survival was investigated. Results: Here, we show that VEGF and EMT markers expression were significantly correlated with depth of tumor invasion and GC stage ( P < .05), degree of differentiation and lymph node metastasis ( P < .001). We found that the rate of VEGF positivity in GC tissues was 52.05%, which was significantly higher than that in adjacent cancer tissues (16.84%). In GC, the association between VEGF and E-cadherin was negative ( r = −0.188, P < .05), whereas VEGF and N-cadherin were positively correlated ( r = 0.214, P < .05). Furthermore, the Kaplan-Meier analysis and a Cox regression model were used to analyze the effect of VEGF and EMT marker expression on the survival of the patients. We found that the overall survival of GC patients was correlated with VEGF ( P < .001), N-cadherin ( P < .001), E-cadherin ( P = .002) expression, and some histopathologic features. Conclusions: Vascular endothelial growth factor and EMT markers exist side by side and play a part together in the development of GC, which provides new ideas for evaluating the prognosis of GC and researching targeted drugs.Keywords
Funding Information
- Funding Natural Science Research Project of Anhui Educational Committee (grant no. KJ2021A0714)
- the 512 Talent Cultivation Plan of Bengbu Medical College (grant numbers by51201319)
- Research and Innovation Team of Bengbu Medical College (grant no. BYKC201908)
- College Teaching Quality Engineering Project of Anhui Educational Committee (grant no. 2021jyxm0954)
- the College Student Innovation Training Program of Bengbu Medical College (grant no. Byycxz21069)
This publication has 30 references indexed in Scilit:
- EMT: Mechanisms and therapeutic implicationsPharmacology & Therapeutics, 2018
- VEGF as a potential target in lung cancerExpert Opinion on Therapeutic Targets, 2017
- Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerInternational Journal of Molecular Sciences, 2017
- Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agentsPharmacology & Therapeutics, 2016
- Mechanisms and regulation of endothelial VEGF receptor signallingNature Reviews Molecular Cell Biology, 2016
- Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their CrosstalksJournal of Clinical Medicine, 2016
- Pulp-dentin RegenerationJournal of Dental Research, 2015
- Vascular Endothelial Growth FactorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006
- Angiogenesis and Lung Cancer: Prognostic and Therapeutic ImplicationsJournal of Clinical Oncology, 2005